Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Meropenem and Aztreonam in APD Patients
NCT07113574Phase 3Completed
- Sponsor
- Karl Landsteiner Institute for Nephrology and Haemato-Oncology
- Start
- Aug 2021
- Primary completion
- Jul 2022
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of meropenem, aztreonam in peritoneal dialysis-associated peritonitis, sponsored by Karl Landsteiner Institute for Nephrology and Haemato-Oncology. Started Aug 2021; status: completed.
02
Drugs
meropenemaztreonam
03
Conditions
peritoneal dialysis-associated peritonitis
Beyond the preview
Go deeper on NCT07113574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07113574.